Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Analyses on a Validation Series of Patients With Waldenström's Disease: Validation of International Prognostic Indexes, Evaluation of Progression-free Survival as a Surrogate Endpoint for Overall Survival. A FILO Study.

NCT05911802 is registered in ClinicalTrials.gov with French Innovative Leukemia Organisation as lead sponsor.

NCT NCT05911802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05911802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Analyses on a Validation Series of Patients With Waldenström's Disease: Validation of International Prognostic Indexes, Evaluation of Progression-free Survival as a Surrogate Endpoint for Overall Survival. A FILO Study.
Lead sponsor
French Innovative Leukemia Organisation
Phase
Observational
Overall status
Recruiting
Start date
August 11, 2023
Completion date
June 15, 2030
Enrollment
500 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

prognostic index, waldenstrom's disease